Article info

Download PDFPDF
Original article
Direct comparison of clinical decision limits for cardiac troponin T and I

Authors

  • Dorien M Kimenai Department of Clinical Chemistry, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Ronald MA Henry Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands Department of Medicine, MUMC+, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Carla JH van der Kallen Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands Department of Medicine, MUMC+, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Pieter C Dagnelie Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands Department of Epidemiology, MUMC+, Maastricht, The Netherlands School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Miranda T Schram Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands Department of Medicine, MUMC+, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Coen DA Stehouwer Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands Department of Medicine, MUMC+, Maastricht, The Netherlands School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Jeroen DE van Suijlen Department of Clinical Chemistry, Gelre Hospital, Apeldoorn, The Netherlands PubMed articlesGoogle scholar articles
  • Marijke Niens Department of Clinical Chemistry, Gelre Hospital, Apeldoorn, The Netherlands PubMed articlesGoogle scholar articles
  • Otto Bekers Department of Clinical Chemistry, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Simone JS Sep Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands Department of Medicine, MUMC+, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Nicolaas C Schaper Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands Department of Medicine, MUMC+, Maastricht, The Netherlands School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Marja P van Dieijen-Visser Department of Clinical Chemistry, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Steven JR Meex Department of Clinical Chemistry, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Steven JR Meex, Department of Clinical Chemistry, Maastricht University Medical Centre (MUMC+), PO Box 5800, Maastricht 6202 AZ, The Netherlands; steven.meex{at}mumc.nl
View Full Text

Citation

Kimenai DM, Henry RM, van der Kallen CJ, et al
Direct comparison of clinical decision limits for cardiac troponin T and I

Publication history

  • Received October 30, 2015
  • Revised December 18, 2015
  • Accepted December 21, 2015
  • First published January 21, 2016.
Online issue publication 
March 24, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.